ID   RS773
AC   CVCL_WS98
SY   RS-773
DR   Wikidata; Q98129191
RX   PubMed=22167753;
RX   PubMed=27467923;
RX   PubMed=29533902;
CC   Problematic cell line: Misclassified. Originally thought to be a Hodgkin lymphoma cell line, but seems to be a B-lymphoblastoid cell line (PubMed=29533902).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000027.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 5
//
RX   PubMed=22167753; DOI=10.1182/blood-2011-07-370841;
RA   Zocchi M.R., Catellani S., Canevali P., Tavella S., Garuti A.,
RA   Villaggio B., Zunino A., Gobbi M., Fraternali-Orcioni G., Kunkl A.,
RA   Ravetti J.L., Boero S., Musso A., Poggi A.;
RT   "High ERp5/ADAM10 expression in lymph node microenvironment and
RT   impaired NKG2D ligands recognition in Hodgkin lymphomas.";
RL   Blood 119:1479-1489(2012).
//
RX   PubMed=27467923; DOI=10.1080/2162402X.2015.1123367;
RA   Zocchi M.R., Camodeca C., Nuti E., Rossello A., Vene R., Tosetti F.I.,
RA   Dapino I., Costa D., Musso A., Poggi A.;
RT   "ADAM10 new selective inhibitors reduce NKG2D ligand release
RT   sensitizing Hodgkin lymphoma cells to NKG2D-mediated killing.";
RL   OncoImmunology 5:e1123367.1-e1123367.10(2016).
//
RX   PubMed=29533902; DOI=10.1515/hsz-2017-0321;
RA   Drexler H.G., Pommerenke C., Eberth S., Nagel S.;
RT   "Hodgkin lymphoma cell lines: to separate the wheat from the chaff.";
RL   Biol. Chem. 399:511-523(2018).
//